Xiao-Ping Chen (Xiaoping Chen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Coronary Artery Disease

Top Venues

Journal of translational medicine

CNS neuroscience & therapeutics

JMIR mHealth and uHealth

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Weijie Ye, Xisong Liang, Ge Chen, Qiao Chen, Hao Zhang, Nan Zhang, Yuanfei Huang, Quan Chen, Xiao-Ping Chen
NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single-cell RNA-seq and in vitro experiment. CNS neuroscience & therapeutics 30 (7) (2024)
Tao Wang, Si-Qin Wang, Yin-Xiao Du, Dan-Dan Sun, Chang Liu, Shuang Liu, Ying-Ying Sun, Hai-Long Wang, Chun-Sheng Zhang, Hai-Long Liu, Lei Jin, Xiao-Ping Chen
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile. Journal of translational medicine 22 (1) (2024)
Tao Wang, Si-Qin Wang, Yin-Xiao Du, Dan-Dan Sun, Chang Liu, Shuang Liu, Ying-Ying Sun, Hai-Long Wang, Chun-Sheng Zhang, Hai-Long Liu, Lei Jin, Xiao-Ping Chen
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile. Journal of translational medicine 22 (1) (2024)
Weijie Ye, Xisong Liang, Ge Chen, Qiao Chen, Hao Zhang, Nan Zhang, Yuanfei Huang, Quan Chen, Xiao-Ping Chen
NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single-cell RNA-seq and in vitro experiment. CNS neuroscience & therapeutics 30 (7) (2024)
Tao Wang, Si-Qin Wang, Yin-Xiao Du, Dan-Dan Sun, Chang Liu, Shuang Liu, Ying-Ying Sun, Hai-Long Wang, Chun-Sheng Zhang, Hai-Long Liu, Lei Jin, Xiao-Ping Chen
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile. Journal of translational medicine 22 (1) (2024)
Wei Zhang, Jiecan Zhou, Yongchao Gao, Fazhong He, Heng Xu, Xiao-Ping Chen, Wei Zhang, Ling Chen
Fas-Associated Factor 1 Promotes Hepatic Insulin Resistance via JNK Signaling Pathway. Oxidative medicine and cellular longevity 2021 (2021)
Lu Zhang, Howard L McLeod, Ke-Ke Liu, Wen-Hui Liu, Hang-Xing Huang, Ya-Min Huang, Shu-Sen Sun, Xiao-Ping Chen, Yao Chen, Fang-Zhou Liu, Jian Xiao
Correction: Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial. JMIR mHealth and uHealth 9 (9) (2021)
Lu Zhang, Howard L McLeod, Ke-Ke Liu, Wen-Hui Liu, Hang-Xing Huang, Ya-Min Huang, Shu-Sen Sun, Xiao-Ping Chen, Yao Chen, Fang-Zhou Liu, Jian Xiao
Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial. JMIR mHealth and uHealth 9 (8) (2021)
Yan-Ling Liu, Xiao-Lei Hu, Pei-Yuan Song, He Li, Mu-Peng Li, Yin-Xiao Du, Mo-Yun Li, Qi-Lin Ma, Li-Ming Peng, Ming-Yu Song, Xiao-Ping Chen
Influence of GAS5/MicroRNA-223-3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease. Journal of the American Heart Association 10 (21) (2021)
Wen-Jing Zeng, Quan Chen, Zhi-Peng Wen, Jie-Ya Wang, Yan-Hong Chen, Jie Zhao, Zhi-Cheng Gong, Xiao-Ping Chen
Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. Journal of cellular and molecular medicine 24 (17) (2020)
Kong-Xiang Zhu, Pei-Yuan Song, null He-Li, Mu-Peng Li, Yin-Xiao Du, Qi-Lin Ma, Li-Ming Peng, Xiao-Ping Chen
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease. European journal of clinical pharmacology 77 (3) (2020)